Clinical Trial Update: Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating fruquintinib combined with mFOLFOX6/mFOLFIRI as first-line treatment for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Zhou Fuxiang | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN